Thursday June 4, 2020

Investors tell Trinity Biotech to find a buyer

Company shares collapsed 50% after it withdrew key heart attack test

Ian Guider

Markets Editor

9th October, 2016

Trinity Biotech, the Bray-based maker of medical diagnosis equipment, has been told by investors to find a buyer for the company.

Trinity Biotech’s shares collapsed 50 per cent last week after it agreed to withdraw a key heart attack test from trial following concerns by regulators. Several investors in the company, whose shares trade on New York’s Nasdaq stock market, were also critical of its management team. The company said it would take a once-off...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The former NTMA head says he is ‘quite alarmed’ at the potential for legal actions over the large number of deaths in nursing homes during the crisis

Michael Brennan | 1 month ago

Oil storage in the self-styled ‘Pipeline Crossroads of the World’ is full to the brim, but the black stuff keeps on coming. With much of the world’s economy in a Covid-19 slowdown, at one point last week, benchmark US crude oil was priced at minus $37.63 a barrel

Barry J Whyte | 1 month ago

Every time Donald Trump spoke on the Covid-19 crisis last week, the stock markets plunged by another point

Marion McKeone | 2 months ago